| Glynnis Ingall, | |
|
2211 Lomas Blvd Ne, Albuquerque, NM 87106-2719 | |
| (505) 272-2445 | |
| Not Available |
| Full Name | Glynnis Ingall |
|---|---|
| Gender | Female |
| Speciality | Pathology - Anatomic Pathology & Clinical Pathology |
| Location | 2211 Lomas Blvd Ne, Albuquerque, New Mexico |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003084435 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 2002-0480 (New Mexico) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Glynnis Ingall, 933 Bradbury Dr Se, Suite 2222, Albuquerque, NM 87106-4374 Ph: (505) 272-3120 | Glynnis Ingall, 2211 Lomas Blvd Ne, Albuquerque, NM 87106-2719 Ph: (505) 272-2445 |
News Archive
PRI's "The World" reports on an epidemic of an unexplained kidney disease that is affecting rural workers across Central America, writing, "[I]t's the second biggest cause of death among men in El Salvador, and in Nicaragua it's a bigger killer of men than HIV and diabetes combined," and "the latest theory is that the victims are literally working themselves to death."
It has been known that diesel exhaust may be a probable carcinogen. But the 20-year study from the National Cancer Institute took a closer look in the Diesel Exhaust in Miners Study, which followed 12,315 miners working in eight underground nonmetal mining facilities. Data were collected on the miners' health and exposure to various elements and chemicals from the time when the mine company first introduced diesel-powered equipment (between 1947 and 1967) until the end of the study in 1997. They breathed varying levels of exhaust from diesel-powered equipment, levels higher than the general population encounters.
The State Department's "Conversations with America" series will soon feature for on-demand viewing a discussion titled "Global Health in Transition."
The results of three clinical trials published on Wednesday in the New England Journal of Medicine show that the antiretroviral drug Truvada, a combination of tenofovir and emtracitabine, can be "highly effective at preventing infection in HIV-free individuals - as long as those individuals take the drug every day as prescribed," CNN's "The Chart" reports (7/11).
Navidea Biopharmaceuticals, Inc., a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that it has reached agreement with the U.S. Food and Drug Administration for two special protocol assessments for the Company's pivotal Phase 3 program with NAV5001 as an aid in the differential diagnosis of Parkinsonian Syndromes from non-Parkinsonian tremor.
› Verified 4 days ago
Dr. Larry Wayne Massie, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 1501 San Pedro Dr Se, Albuquerque, NM 87108 Phone: 505-256-5770 Fax: 505-256-5439 | |
Jennifer L Wheeler Buenger, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: Msc 10 5590, 1 University Of New Mexico, Albuquerque, NM 87131 Phone: 505-272-3053 Fax: 505-925-0546 | |
Dr. Joseph Ross Griggs, D.O. Pathology Medicare: Accepting Medicare Assignments Practice Location: Msc 08 4640, 1 University Of New Mexico, Albuquerque, NM 87131 Phone: 505-272-4814 Fax: 505-272-8084 | |
Zoe Sarah Sundell, MD Pathology Medicare: Medicare Enrolled Practice Location: 1 University Of New Mexico, Albuquerque, NM 87131 Phone: 505-272-4814 | |
Anne Bracey, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: Unm Hospital Pathology, 2211 Lomas Blvd Ne, Albuquerque, NM 87131 Phone: 505-272-6225 | |
Dr. James Anthony Halfacre Jr., M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 1100 Central Ave Se, Albuquerque, NM 87106 Phone: 505-841-1234 |